Question 34 (part 2) · LEK · Medical experiment
Is it ethical to invite a severely sick patient, who requires constant treatment, to randomized clinical double-blind study of healing properties of new inhibitor of angiotensin converting enzyme with placebo?
- A. no, because during participation, the patient may be devoid of benefits of treatment with inhibitors of already approved action.
- B. yes, if using placebo is important to the credibility of the result and the patient was informed of placebo use.
- C. yes, if the risk is proportional to the scientific and social value.
- D. no, using placebo is allowed only in studying drugs used in harmless diseases.
- E. yes, but only under the condition, that the doctor makes key decisions for the patients.
Hint
Consider what a severely ill patient would lose by receiving placebo when an effective drug class already exists.
The answer, the explanation and a note on every option are available once you log in. The account is free: topic tests, a mock exam, mistake review and statistics.
More questions on Bioethics and medical law
- The factors authorizing to determine death in a patient are:
- Indicate the true sentence:
- One of the family doctor’s duties is to keep medical records. The individual documentation of the patient consists of the internal documentation…
- Forensic psychiatric opinions in criminal cases are associated with:
- Which of the following cannot be a preventive measure, ordered by the court, for a mentally ill patient who committed a crime?
- According to the article 23 of the act on the mental health, a person can be hospitalized at the psychiatric hospital without their consent if: